Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.

Matthew J. Ellis(Guardant (United States)), Robert Clarke(University of Oxford), William R. Miller(Houston Methodist), Minetta C. Liu(Mayo Clinic), Marc E. Lippman(Georgetown University), Ann Gallagher, Natalie Davis, Chris G. Russell, Vered Stearns(Johns Hopkins University), Theodore N. Tsangaris(Georgetown University), Richard Y. Lee, Baljit Singh(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences), Daniel F. Hayes(University of Michigan–Ann Arbor), Andrew Coop, Aiyi Liu, Alan Zwart, Rujirutana Srikanchana(Catholic University of America), Lisa M. Schumaker, Yue Wang(Catholic University of America), Marie Pennanen(Unknown)
PubMed
May 1, 2002
Cited by 114

Related Papers

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples
|Epidemiology|2004|1.2k